Introduction
Utilizing Next-Generation Sequencing (NGS) technology, we perform whole-exome sequencing (WES), covering at least 5,108 genes. By integrating biomedical big data analysis and an international-grade gene interpretation system, we effectively analyze the correlation between genetic variations and clinical phenotypes. The scope of testing includes mutations in gene exons (point mutations, small insertions/deletions), as well as key mutations (point mutations, small insertions/deletions) in select intronic and promoter regions.
Features / strengths
1. International Standards, Local Services
2. National Laboratory Quality Certification
3. Using NGS Leading Technology
4. Fast and Accurate Report Issuance
5. Complete Clinical Trial Basis
Specification in detail
